N Söderlund1, K Zwi, A Kinghorn, G Gray. 1. Centre for Health Policy, University of the Witwatersrand PO Box 1038, Johannesburg 2000, South Africa. soderlun@icon.co.za
Abstract
OBJECTIVE: To assess the cost effectiveness of vertical transmission prevention strategies by using a mathematical simulation model. DESIGN: A Markov chain model was used to simulate the cost effectiveness of four formula feeding strategies, three antiretroviral interventions, and combined formula feeding and antiretroviral interventions on a cohort of 20 000 pregnancies. All children born to HIV positive mothers were followed up until age of likely death given current life expectancy and a cost per life year gained calculated for each strategy. SETTING: Model of working class, urban South African population. RESULTS: Low cost antiretroviral regimens were almost as effective as high cost ones and more cost effective when formula feeding interventions were added. With or without formula feeding, low cost antiretroviral interventions were likely to save lives and money. Interventions that allowed breast feeding early on, to be replaced by formula feeding at 4 or 7 months, seemed likely to save fewer lives and offered poorer value for money. CONCLUSIONS: Antiretroviral interventions are probably cost effective across a wide range of settings, with or without formula feeding interventions. The appropriateness of formula feeding was highly cost effective only in settings with high seroprevalence and reasonable levels of child survival and dangerous where infant mortality was high or the protective effect of breast feeding substantial. Pilot projects are now needed to ensure the feasibility of implementation.
OBJECTIVE: To assess the cost effectiveness of vertical transmission prevention strategies by using a mathematical simulation model. DESIGN: A Markov chain model was used to simulate the cost effectiveness of four formula feeding strategies, three antiretroviral interventions, and combined formula feeding and antiretroviral interventions on a cohort of 20 000 pregnancies. All children born to HIV positive mothers were followed up until age of likely death given current life expectancy and a cost per life year gained calculated for each strategy. SETTING: Model of working class, urban South African population. RESULTS: Low cost antiretroviral regimens were almost as effective as high cost ones and more cost effective when formula feeding interventions were added. With or without formula feeding, low cost antiretroviral interventions were likely to save lives and money. Interventions that allowed breast feeding early on, to be replaced by formula feeding at 4 or 7 months, seemed likely to save fewer lives and offered poorer value for money. CONCLUSIONS: Antiretroviral interventions are probably cost effective across a wide range of settings, with or without formula feeding interventions. The appropriateness of formula feeding was highly cost effective only in settings with high seroprevalence and reasonable levels of child survival and dangerous where infant mortality was high or the protective effect of breast feeding substantial. Pilot projects are now needed to ensure the feasibility of implementation.
Authors: M J Mayaux; J P Teglas; L Mandelbrot; A Berrebi; H Gallais; S Matheron; N Ciraru-Vigneron; F Parnet-Mathieu; A Bongain; C Rouzioux; J F Delfraissy; S Blanche Journal: J Pediatr Date: 1997-12 Impact factor: 4.406
Authors: R J Biggar; P G Miotti; T E Taha; L Mtimavalye; R Broadhead; A Justesen; F Yellin; G Liomba; W Miley; D Waters; J D Chiphangwi; J J Goedert Journal: Lancet Date: 1996-06-15 Impact factor: 79.321
Authors: J Bertolli; M E St Louis; R J Simonds; P Nieburg; M Kamenga; C Brown; M Tarande; T Quinn; C Y Ou Journal: J Infect Dis Date: 1996-10 Impact factor: 5.226
Authors: E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson Journal: N Engl J Med Date: 1994-11-03 Impact factor: 91.245
Authors: R D Semba; P G Miotti; J D Chiphangwi; A J Saah; J K Canner; G A Dallabetta; D R Hoover Journal: Lancet Date: 1994-06-25 Impact factor: 79.321